ArticleJournal of clinical hypertension (Greenwich, Conn.)2019
Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05034354 (Development and Feasibility of a Virtual Remote Physiological Monitoring Program of Children With Heart Disease), which is not on this map. Cited by 20 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development and Feasibility of a Virtual Remote Physiological Monitoring Program of Children With Heart Disease
Who cites it
20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 35 citations in OpenAlex.
- Pooled it
- Economic Evaluation of Pharmacist-Led Digital Health Interventions: A Systematic Review.International journal of environmental research and public health · 2022Pooled it
- Domains and Methods Used to Assess Home Telemonitoring Scalability: Systematic Review.JMIR mHealth and uHealth · 2021Pooled it
- Choice of home blood pressure monitoring device: the role of device characteristics among Alaska Native and American Indian peoples.BMC cardiovascular disorders · 2022Trial
- Pharmacist-Directed Self-Management of Blood Pressure Versus Conventional Management in Patients with Hypertension: A Randomized Control Trial.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2021Trial
- A Scoping Review of Methods for Extrapolating Costs and Effects in Economic Evaluations of Remote Monitoring.PharmacoEconomics - open · 2026Review
- Identifying and Comparing Intervention Cost Components in Remote Patient Monitoring: A Scoping Review.PharmacoEconomics · 2026Article
- Long-term cost-effectiveness of pharmacist-managed hypertension care in China.BMC health services research · 2025Article
- Prerequisites for Cost-Effective Home Blood Pressure Telemonitoring: Early Health Economic Analysis.JMIR cardio · 2025Article
- Feasibility of in-home monitoring for people with glaucoma: the I-TRAC mixed-methods study.Health technology assessment (Winchester, England) · 2024Article
- Cost-Effectiveness of a Workplace-Based Hypertension Management Program in Real-World Practice in the Kailuan Study.Journal of the American Heart Association · 2024Article
- Bottom-Up Analysis of Telemonitoring Costs: A Case Study in Slovenian Primary Care.Zdravstveno varstvo · 2024Article
- Trends of Multimorbidity Patterns over 16 Years in Older Taiwanese People and Their Relationship to Mortality.International journal of environmental research and public health · 2022Article
- Virtual Care With Digital Technologies for Rural Canadians Living With Cardiovascular Disease.CJC open · 2022Review
- The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future.Connected health · 2022Article
- Impact of Home Telemonitoring and Management Support on Blood Pressure Control in Nondialysis CKD: A Systematic Review and Meta-Analysis.Canadian journal of kidney health and disease · 2022Article
- Telemonitoring and Case Management for Hypertensive and Remote-Dwelling Patients With Chronic Kidney Disease-The Telemonitoring for Improved Kidney Outcomes Study (TIKO): A Clinical Research Protocol.Canadian journal of kidney health and disease · 2022Article
- Home blood pressure telemonitoring for improving blood pressure control in middle-aged and elderly patients with hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2021Article
- Cost-effectiveness of home blood pressure telemonitoring and case management in the secondary prevention of cerebrovascular disease in Canada.Journal of clinical hypertension (Greenwich, Conn.) · 2019Article
- Pharmacist-led hypertension management combined with blood pressure telemonitoring in a primary care setting may be cost-effective in high-risk patients.Journal of clinical hypertension (Greenwich, Conn.) · 2019Article
Corrections and comments
- Commented on by
Authors and funding
12 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Home blood pressure (BP) telemonitoring and pharmacist case management reduce BP, but cost-effectiveness assessments are mixed. We examined the incremental cost-effectiveness of this intervention vs usual care in Canadians with cerebrovascular disease. A Markov decision model cost-utility analysis examining community-residing, high-risk patients with a recent nondisabling cerebrovascular event was created. A lifetime time horizon and health care payer perspective were used. Achieved BP, future cardiovascular risks, and attendant consequences on quality-adjusted life years and Canadian dollar costs were modeled. BP telemonitoring was assumed to occur for 3 months, then quarterly. Life tables were used to determine overall mortality, adjusted by cardiovascular disease mortality. Relative efficacies of intervention-associated BP lowering, resource use, and costs were obtained from Canadian published literature. Reduction in systolic BP of 9.7 mmHg was used in the base case; subsequently, robust sensitivity analyses were conducted. The results showed that, over the lifetime horizon, telemonitoring with case management led to net health care savings of $1929 Canadian and increased per-patient QALYs by 0.83. These findings were robust to sensitivity analysis, with the intervention remaining dominant or highly cost-effective. Increasing telemonitoring costs by 50% still resulted in the intervention being dominant; if the costs of telemonitoring plus case management were 2-3 times base case cost, incremental cost-effectiveness was $1200-$4700 per quality-adjusted life year gained. In conclusion, home BP telemonitoring and pharmacist case management poststroke lowered costs and improved QALYs. Strategies and funding for broad implementation of this dominant strategy should be implemented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.